ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes. [electronic resource]
Producer: 20130531Description: JC8 p. digitalISSN:- 1539-3704
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.